Immunocore Holdings PLC - American Depositary Shares (IMCR) closed at $30.99 on November 6, 2026, up 9.1% from the previous close, on volume of 1,493,421 shares (30-day average 473,885).
Data as of November 6, 2026.
6-Nov-2026
| # | Date | Strategy | Legs | Contracts |
|---|---|---|---|---|
| 1 | Oct 16, 2026 | Straddle or Synthetic | 18-Dec-2630 C : 30 P | 600 |
Ranked by contracts: multi-leg trades of 200 or more contracts on one day, through Nov 6, 2026. See the 10 largest for 30, 60 and 90 days
Globe Newswire (Fri, 6-Nov 12:00 PM ET)
Immunocore reports third quarter financial results and provides a business update
Globe Newswire (Fri, 6-Nov 9:00 AM ET)
H.C. Wainwright Sticks to Their Buy Rating for Immunocore Holdings (IMCR)
TipRanks (Wed, 4-Nov 12:45 PM ET)
Globe Newswire (Thu, 29-Oct 9:00 AM ET)
Globe Newswire (Thu, 15-Oct 7:00 AM ET)
Globe Newswire (Mon, 14-Sep 7:00 AM ET)
Immunocore to present at upcoming investor conferences
Globe Newswire (Tue, 1-Sep 7:00 AM ET)
Immunocore Holdings PLC is a commercial-stage biotechnology company. Using its ImmTAX platform, the company is developing a deep pipeline in multiple therapeutic areas, including clinical stage programs in oncology and infectious disease, pre-clinical programs in autoimmune disease, and earlier pre-clinical programs across three therapeutic areas. The company's main product, KIMMTRAK, is used for the treatment of unresectable or metastatic uveal melanoma (mUM). The other drug candidates in its pipeline include Brenetafusp, IMC-P115C, IMC-T119C, IMC-R117C, IMC-S118AI, IMC-U120AI, and others, being developed as a potential treatment for various oncology, infectious, and autoimmune diseases.
Immunocore Holdings PLC - American Depositary Shares trades on the NASDAQ stock market under the symbol IMCR.
As of November 6, 2026, IMCR stock price climbed to $30.99 with 1,493,421 million shares trading.
IMCR has a beta of -0.02, meaning it tends to be less sensitive to market movements. IMCR has a correlation of 0.00 to the broad based SPY ETF.
IMCR has a market cap of $1.60 billion. This is considered a Small Cap stock.
Last quarter Immunocore Holdings PLC - American Depositary Shares reported $116 million in Revenue and -$.02 earnings per share. This beat revenue expectation by $5 million and missed earnings estimates by -$.04.
In the last 3 years, IMCR traded as high as $76.98 and as low as $23.15.
The top ETF exchange traded funds that IMCR belongs to (by Net Assets): IBB, SPDW, SBIO, BBP, CANC.
IMCR has underperformed the market in the last year with a return of -1.9%, while the SPY ETF gained +10.8%. In the last 3 month period, IMCR fell short of the market, returning -10.2%, while SPY returned -4.1%. However, in the most recent 2 weeks IMCR has outperformed the stock market by returning 0.0%, while SPY returned -3.2%.
IMCR support price is $27.34 and resistance is $29.46 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that IMCR shares will trade within this expected range on the day.
